Enliven Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $53k | 3.4k | 15.40 |
| 2025-09-30 | $71k | 3.4k | 20.47 |
| 2025-06-30 | $69k | 3.4k | 20.06 |
| 2025-03-31 | $68k | 3.4k | 19.68 |
| 2024-12-31 | $78k | 3.4k | 22.50 |
| 2024-09-30 | $88k | 3.4k | 25.54 |
| 2024-06-30 | $81k | 3.4k | 23.37 |
| 2024-03-31 | $34k | 1.9k | 17.59 |
| 2023-12-31 | $27k | 1.9k | 13.84 |
| 2023-09-30 | $26k | 1.9k | 13.66 |
| 2023-06-30 | $39k | 1.9k | 20.41 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors